Weil Company’s Endava DAVA Stock Holding History

Weil Company’s Portfolio DAVA Stock Details DAVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,658	Closed	-$267K	–	139
2023 Q3	$267K	Buy	+4,658	New	+$243K	0.13%	110

Other funds holding DAVA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

CDAM (UK) London, United Kingdom $451M AUM 6.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Weil Company's DAVA Position: Q4 2023 in Review

Weil Company sold out of Endava (DAVA) in Q4 2023, closing a stake of 4,658 shares — an estimated $267K sold.

Weil Company first reported a position in DAVA in Q3 2023 and held it in 1 quarter. The position peaked at $267K in Q3 2023. 194 funds tracked by Wall St. Rank hold DAVA as of Q4 2023.

Weil Company reported no remaining Endava position as of Q4 2023 after selling out during the quarter.
Weil Company sold 4,658 Endava shares in Q4 2023, an estimated $267K.
Weil Company first reported a position in Endava in Q3 2023 and held it in 1 quarter.
Weil Company's Endava position peaked at $267K in Q3 2023.
194 funds tracked by Wall St. Rank held Endava as of Q4 2023.

Based on Weil Company's 13F filing for Q4 2023, filed 9 Feb 2024.